JOINT FILING AGREEMENTJoint Filing Agreement • January 21st, 2020 • Opaleye Management Inc. • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated January 21, 2020 (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of ArTara Therapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
